Sarepta Therapeutics (SRPT) Awaits Q1 Earnings with Mixed Projections
Sarepta Therapeutics (SRPT) is expected to release Q1 earnings with an anticipated EPS of -$0.65. Revenue is projected to grow by 65.4%, reaching $684.1
Sarepta Therapeutics (SRPT, Financial) is expected to release Q1 earnings with an anticipated EPS of -$0.65.
Revenue is projected to grow by 65.4%, reaching $6...
Read More
Other Stories in Business
- Gulf War veteran executed for 1998 quadruple murder despite claims of mental illness
- Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth
- Connecting Asia's startup ecosystem
- Connecting Asia's startup ecosystem
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- Business First Bancshares, Inc. (BFST) Q1 2025 Earnings Call Transcript
